Target intelligence / Profile preview

Helicobacter pylori surface antigens and urease (H. pylori antigens/urease)

Target
H. pylori antigens/urease
Molecular classification
Enzyme, Bacterial surface protein, Adhesin, Toxin, Antigen
01

Overview

Helicobacter pylori surface antigens and urease represent a complex of proteins essential for the survival, colonization, and pathogenicity of the H. pylori bacterium in the human stomach. Urease is a nickel-dependent enzyme that catalyzes the hydrolysis of urea into ammonia and carbon dioxide, effectively neutralizing gastric acid to create a habitable microenvironment for the bacteria (StatPearls, 2023). Surface antigens include adhesins like BabA and SabA, which facilitate attachment to the gastric epithelium, and major virulence factors such as CagA (Cytotoxin-associated gene A) and VacA (Vacuolating cytotoxin A) (PubMed, 2021). These components are primary targets for diagnostic tests, such as the urea breath test, and are the focus of vaccine development aimed at preventing chronic gastritis, peptic ulcers, and gastric cancer (NIH, 2022). Therapeutic strategies involve inhibiting urease activity or using bismuth-based compounds to disrupt bacterial cell wall integrity and adhesion (PubChem). This target entry is considered incorrect as a single molecular entity because it groups multiple distinct proteins with different functions into one category.

Other names
H. pylori virulence factorsHelicobacter pylori antigensUrease and outer membrane proteinsCagAVacABabASabA
02

Mechanism of action

Inhibition of the urease enzyme to prevent acid neutralization, blocking of bacterial adhesion to gastric mucosa, and induction of neutralizing antibodies against virulence factors.

03

Biological functions

Acid neutralizationBacterial adhesionPathogenesisImmune evasionProtein secretion
04

Disease associations

GastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphomaInfection
05

Safety considerations

Antibiotic resistance developmentPotential for autoimmune cross-reactivityAlteration of the gastric microbiomeLow vaccine efficacy in clinical trials
06

Interacting drugs

Acetohydroxamic acid

4 more in the full profile.

07

Biomarkers

Urea breath test (UBT)Stool antigen testRapid urease test (RUT)Anti-CagA antibodiesAnti-VacA antibodies

Beyond the preview

Go deeper on Helicobacter pylori surface antigens and urease (H. pylori antigens/urease).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori surface antigens and urease (H. pylori antigens/urease).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call